MarketInOut Stock Screener Log In | Sign Up

AriBioLab Co Ltd

KRX • Healthcare • Biotechnology • Quote as of 10/30/2026
AriBioLab Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization91,504 mln
Float21.39 mln

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.63
Highly reliable

Relative Strength

13 / 100
Significantly lagging

Debt / Equity

0.63
Moderate leverage

Pre-Tax Margin

-8,327%
Severely loss-making

ROE

-103
Deeply negative

Business Description

Cha Vaccine Research Institute, founded in 2000 and based in Seongnam-si, South Korea, is a biotechnology company focused on creating vaccines and immune-based treatments for both infectious and chronic diseases. The company is working on several products at various stages of development, including vaccines targeting hepatitis B, herpes zoster, influenza, and tuberculosis. It is also advancing cancer vaccines and drug therapies designed to help the immune system fight cancer.

Key Fundamentals

EPS-537
ROE-103
RPS6.44
ROIC-81.92
ROA-46.29
EBITDA, mln-12,248
EV / EBITDA-7.43
EV / EBIT-7.19
Revenue, mln173
EV / Revenue526

Quote Details

Last 3,350.00
Change 5 (0.15%)
Open 3,395.00
Volume 146,905
Turnover 492,131,744
Average Volume 422,741

Financial Ratios

Pre-Tax Profit Margin-8,327
Current Ratio1.92
Price / Book9.44
Price / Tangible Book9.67
Debt / Equity0.63
Price / Sales538

Financial Strength

Altman Z-Score-1.83
Piotroski F-Score 4 / 9
Beneish M-Score-3.63

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.84% 14 / 100   
1 Month -10.79% 43 / 100   
2 Months 41.95% 96 / 100   
6 Months -7.2% 77 / 100   
1 Year 25.47% 84 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog